ArticleTherapeutic advances in musculoskeletal disease2024

Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial.

Stefan Siebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.